Encellin harnesses material chemistry innovations to advance the next generation of cell therapies. Their goal is to provide a functional cure for people with unmet clinical needs, beginning with type 1 diabetes. Early in the company’s development, Encellin’s founders felt fortunate to be introduced to First Republic. The Bank helped streamline their day-to-day operations, guiding them to the right products and services for each stage of growth. With a committed banking partner by their side, Encellin is better able to focus on their mission to help millions of patients around the world.